Efficacy of phloroglucinol for the treatment of pain of gynaecologic or obstetrical origin: a systematic review of literature of randomised controlled trials Blanchard ClaraVanderkam PaulBoussageon Rémy Review 21 August 2019 Pages: 1 - 6
Correction to: Efficacy of phloroglucinol for the treatment of pain of gynaecologic or obstetrical origin: a systematic review of literature of randomised controlled trials Clara BlanchardPaul VanderkamRémy Boussageon Correction 23 November 2019 Pages: 7 - 7
Drug-associated non-pyrogenic hyperthermia: a narrative review Koen Sebastiaan BongersMohammed S. SalahudeenGregory M. Peterson Review 23 October 2019 Pages: 9 - 16
Suitability of patient education materials on proton-pump inhibitors deprescribing: a focused review Jérôme Nguyen-SoenenCédric RatJean-Pascal Fournier Review 06 November 2019 Pages: 17 - 21
Systematic review and meta-analysis of the efficacy of clinically tested protectants of cisplatin nephrotoxicity Alfredo G. CasanovaMaría Teresa Hernández-SánchezAna Isabel Morales Clinical Trial 01 November 2019 Pages: 23 - 33
The Danish model for the quick and safe implementation of infliximab and etanercept biosimilars Thomas Bo JensenDorthe BartelsHanne Rolighed Christensen Original Article 01 November 2019 Pages: 35 - 40
Impact of age and CYP2D6 genetics on exposure of aripiprazole and dehydroaripiprazole in patients using long-acting injectable versus oral formulation: relevance of poor and intermediate metabolizer status Marit TveitoEspen MoldenRobert Løvsletten Smith Pharmacogenetics 21 October 2019 Pages: 41 - 49
ABCC2 c.-24 C>T single-nucleotide polymorphism was associated with the pharmacokinetic variability of deferasirox in Chinese subjects Kangna CaoGuanghui RenDi Zhao Pharmacogenetics 01 November 2019 Pages: 51 - 59
Population pharmacokinetics of meropenem in critically ill children with different renal functions Mélanie RappSaïk UrienMehdi Oualha Pharmacokinetics and Disposition 26 October 2019 Pages: 61 - 71
Nortriptyline serum concentration as a predictor for cardiac risk in amitriptyline-treated patients Maike Scherf-ClavelJasper ZebnerStefan Unterecker Pharmacokinetics and Disposition 23 October 2019 Pages: 73 - 80
Purchases of medical therapy recommended for coronary artery disease before and after elective revascularisation Jari HeiskanenJuha HartikainenAnna-Maija Tolppanen Pharmacoepidemiology and Prescription Open access 11 October 2019 Pages: 81 - 88
Consequences of the new zolpidem prescription regulations: a cohort study from the French national healthcare database J. TouchardP. SabatierB. Sabatier Pharmacoepidemiology and Prescription 13 October 2019 Pages: 89 - 95
Pharmacological treatment patterns in heart failure: a population-based cohort study Pauline Bosco-LévyClélia FavaryCécile Droz-Perroteau Pharmacoepidemiology and Prescription 21 October 2019 Pages: 97 - 106
Second-generation antipsychotics and pregnancy complications Maria EllfolkMaarit K. LeinonenHeli Malm Pharmacoepidemiology and Prescription Open access 03 November 2019 Pages: 107 - 115
Drug interactions between tacrolimus and clotrimazole troche: a data mining approach followed by a pharmacokinetic study Takaya UnoKyoichi WadaMitsutaka Takada Pharmacoepidemiology and Prescription 26 October 2019 Pages: 117 - 125
Pharmacokinetics of cefoperazone/sulbactam in plasma and cerebrospinal fluid in patients with intraventricular hemorrhage after external ventricular drains Liang MengLingti KongXiaofei Wu Letter to the Editor 23 October 2019 Pages: 127 - 129
An unmet medical need vs. regulatory recommendations: how should we treat patients with hyperaldosteronism and advanced chronic kidney disease when surgery is not feasible? Ivana Mikačić Letter to the Editor 29 October 2019 Pages: 131 - 132
A complex interaction between antitubercular treatment and acenocoumarol Saibal DasSapan Kumar BeheraSandhiya Selvarajan Letter to the Editor 29 October 2019 Pages: 133 - 135
